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两部分组成，一部分是 20S 降解复合体，另一部分是 20S 降解复合体（CP）两
端的 19S调节复合体（RP）。20S降解复合体是底物蛋白质的水解中心，由 7个
α亚基和 7个 β亚基，组成 α1-7β1-7β1-7α1-7的桶状结构。在哺乳动物细胞中还有 3
个可以被干扰素（IFNγ）诱导的 β 亚基，β1i，β2i，β5i，可以替换 β1，β2，β5











ORF，把这些亚基 ORF 分别克隆到酵母双杂交的载体上，转入酵母 S.cerevisiae 
AH109中进行亚基间相互作用分析。我们总共得到了 34个 26S蛋白酶体亚基的
全长 ORF，检测了 1156对 26S蛋白酶体亚基间相互作用实验，观察到 112对阳

















们还得到一些新型的 26S 蛋白酶体亚基间相互作用，这为了解人 26S 蛋白酶体
的功能奠定了基础。 
 








































The 26S proteasome is a multi-subunit protein complex commonly available 
in most eukaryotic cells. It is responsible for the degradation of many cellular proteins, 
for example the cell cycle protein, oncogene product and MHC-Ⅰrestricting antigen. 
As a result, it plays a very important role in some cellular process, such as the 
regulation of cell cycle, cell apoptosis, antigen presentation, gene transcription and so 
on. The 26 S proteasome complex is composed of two subcomplexes, the 20 S 
catalytic particle and the 19 S regulatory particle. The 20 S particle has a 
cylinder-shaped structure containing four stacked heptameric rings that form the 
proteolytic chamber. The 20 S cylinder is capped on both sides by a 19 S particle to 
form the 26 S proteasome. The 19 S particle is composed of at least 17 proteins that 
form two subcomplexes; the “base” complex is composed of six AAA family of 
ATPases and three other proteins, and the “lid” complex is composed of eight 
non-ATPase proteins. It is generally believed that the 19 S particle plays two major 
roles in facilitating protein degradation by the 20 S particle. The first is to recognize 
and position ubiquitinated protein substrates, and the second is to unfold the protein 
substrates so that they can be inserted to the proteolytic chamber of the 20 S catalytic 
particle. How these events occur in the 19 S particle is unclear, and how the individual 
subunits participate in the regulatory functions also remains unknown. 
Human liver is a most important part of human tissue, it play the pivot role in 
human activities. The proteasome interaction maps of human liver are very important 
to analysis and cure the human liver disease.  
In this work, proteasome subunit ORFs were isolated from the liver tissues of 
Chinese people and constructed into the yeast two-hybrid plasmids. Then the yeast 
two-hybrid system was applied to detect the interactions between 26S proteasome 
subunits. We obtained 34 proteasome subunit ORFs. After screening 1156 subunit 
interactions, we obtained 112 positive interactions, about 10% of which were verified 













fluoresce tag into the HeLa cells and observed the co-localization of interacting 
subunits. 41% of our obtained 26S proteasome interactions have been reported 
previously. We also obtained many novel 26S proteasome interactions. Our results 
implied some mechanism of the formation of the 26S proteasome complex. 
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催化泛素 (ubiquitin ，Ub) 共价地结合在靶蛋白上，随后靶蛋白被依赖 ATP的 26S
蛋白酶体选择性降解成短肽。Ub首先被 Ub活化酶 ( ubiquitin activating enzymes ，
El) 活化 Ub上 76位的 Gly与 E1上的色氨酸 Cys残基形成高能硫酯键连接在一起；
然后通过转酯作用，Ub从 E1转移到 Ub结合酶 ( ubiquitin conjugating enzymes， E2)
上的色氨酸Cys；活化的Ub再从E2转移到底物特异性的Ub连接酶 ( ubiquitin ligase 
enzymes，E3) 色氨酸 Cys 残基上；接着通过形成底物-E3 复合物 (substrate-E3 
complex )，使底物发生 Ub化即多个 Ub分子通过异肽键 (isopeptide bond) 结合在靶



















图 1.1 泛素降解途径简图[2] 





赖性蛋白激酶 CDK (cyclin-dependent kinase)，抑制子 Sicl就需要在其特定位点的磷
酸化，否则不能被 E3 识别从而不能通过泛素途径降解。这可能导致生物体不能对
细胞周期进行精确调控，引起某些细胞组织或器官发生癌变。现在发现的泛素连接
酶 E3主要有两大类：HECT（homologous to E6-AP carboxyl   terminus）结构域家
族和 RING (the really interesting gene) 结构域家族。HECT结构域主要功能是使泛素



























    26S 蛋白酶体分子由催化颗粒(catalytic particle, CP)和调节颗粒 (regulatory 
particle, RP) 组成，见图 1.2。CP 又称 20 S 降解复合体，RP 又称 19 S 调节复合体，
PA700。20 S 复合体的两侧各有一个 19 S 复合体，在某些情况下还有杂交的蛋白酶
体，一侧为 19 S 复合体，而另一侧为 11s 复合体
[12]
。26S 蛋白酶体亚基命名见表 1.1。 
 
 
                    图 1.2  26s 蛋白水解小体的结构模拟图
[3]
 
      Fig1.2 Structure of the proteasome 
 
1.1.2.1  CP 的结构 
20S 复合体外形呈筒状，由内层 2个β环和外层 2个α环组成，每个环含 7
个不同的亚基，基本结构为α7β7β7α7。人类存在 10 个不同的β亚基和 7个不
同的α亚基。只有 CP 具有蛋白质水解功能，底物的降解主要由它来完成。起催化















被 β1i，β2i，β5i 亚基替代，形成免疫蛋白酶体，和抗原递呈有关。β 亚基的
活性位点是 N端的保守残基苏氨酸（Thr）,不同生物的β亚基 N端的保守残基见图










图1.3  不同生物蛋白酶体的β亚基前导肽序列 
[47,48]
 

























表 1.1 26S蛋白酶体亚基在不同生物中命名表 
Table1.1 Nomenclature of 26S proteasome subunits  
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